MEPERIDINE Side Effects

6412915-3 | Serotonin Syndrome
on Oct 12, 2009 Male patient from CHINA , 41 years of age, was diagnosed with hypertension, induction of anaesthesia, maintenance of anaesthesia and was treated with Meperidine (View Usage). Patient experienced the following unwanted or unexpected effects: serotonin syndrome. Meperidine dosage: 30 Mg, Single. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FENTANYL 100 (150 Ug, Single) (View Fentanyl-100 Review and Fentanyl-100 Label ), PROPOFOL (150 Mg, Single) (View Propofol Review and Propofol Label ), GLYCOPYRROLATE /00196202/ (0.2 Mg, Single) (View Glycopyrrolate /00196202/ Review and Glycopyrrolate /00196202/ Label ), ROCURONIUM BROMIDE (50 Mg, Single) (View Rocuronium Bromide Review and Rocuronium Bromide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), DESFLURANE (View Desflurane Review and Desflurane Label ).

5599329-3 | Cardio-respiratory Arrest
Patient was taking Meperidine (View Usage). Patient had the following side effects: cardio-respiratory arrest on Jan 11, 2008 from UNITED STATES Additional patient health information: Male patient , 53 years of age, . Meperidine dosage: .

4933076-3 | Grand Mal Convulsion
Adverse event was reported on Mar 02, 2006 by a Female patient taking Meperidine (View Usage) (Dosage: 10mg/h Basal 20mg/8min Iv) was diagnosed with pancreatitis acute and. Location: UNITED STATES , 28 years of age, After Meperidine was administered, patient had the following side effects: grand mal convulsion. Patient was hospitalized.

4764274-X | Cardiopulmonary Failure, Duodenal Ulcer, Gastric Ulcer Perforation, Hypoxia, Procedural Complication, Upper Gastrointestinal Haemorrhage
on Sep 07, 2005 Female patient from UNITED STATES , 84 years of age, weighting 138.0 lb, was diagnosed with endoscopy (What is endoscopy?) and was treated with Meperidine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiopulmonary failure, duodenal ulcer, gastric ulcer perforation, hypoxia, procedural complication, upper gastrointestinal haemorrhage. Meperidine dosage: 25 Mg Iv X 1. During the same period patient was treated with MIDAZOLAM (4 Mg Iv X 1) (View Midazolam Review and Midazolam Label ), LASIX (View Lasix Review and Lasix Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LANTUS (View Lantus Review and Lantus Label ), PREVACID (View Prevacid Review and Prevacid Label ), FRAGMIN (View Fragmin Review and Fragmin Label ).


4727372-2 | Hypotension, Oxygen Saturation Decreased, Post Procedural Complication, Unresponsive To Verbal Stimuli
on Jul 27, 2005 Female patient from UNITED STATES , 78 years of age, weighting 200.0 lb, was diagnosed with sedation and was treated with Meperidine (View Usage). Patient had the following side effects: hypotension, oxygen saturation decreased, post procedural complication, unresponsive to verbal stimuli. Meperidine dosage: 50 Mg Iv. During the same period patient was treated with MIDAZOLAM (3 Mg Iv) (View Midazolam Review and Midazolam Label ), STARLIX (View Starlix Review and Starlix Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), VICODIN (View Vicodin Review and Vicodin Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

4715504-1 | Convulsion
Patient was taking Meperidine (View Usage). After Meperidine was administered, patient had the following side effects: convulsion on Jul 15, 2005 from UNITED STATES Additional patient health information: Male patient , 43 years of age, weighting 148.4 lb, . Meperidine dosage: .

4636472-7 | Dyspnoea
Adverse event was reported on Apr 13, 2005 by a Male patient taking Meperidine (View Usage) (Dosage: 100 Mg, Q4h Iv Push) . Location: , 59 years of age, weighting 207.9 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea. During the same period patient was treated with HUMULIN R (View Humulin R Review and Humulin R Label ), HEPARIN (View Heparin Review and Heparin Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), MEPERIDINE HCL (View Meperidine Hcl Review and Meperidine Hcl Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), THERAPEUTIC VITAMIN W./MIN TAB (View Therapeutic Vitamin W./min Tab Review and Therapeutic Vitamin W./min Tab Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

4582753-5 |
on Oct 06, 2004 Female patient from , 17 years of age, was treated with Meperidine (View Usage). . Meperidine dosage: . During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ).